FDA
Ziprasidone Mesylate
The FDA lists this product in 3 strengths and forms.
Composition
- Active ingredients
- ZIPRASIDONE MESYLATE EQ 20MG BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ZIPRASIDONE MESYLATE EQ 20MG BASE/VIAL · PowderANDA217595-001 · Prescription
- ZIPRASIDONE MESYLATE EQ 20MG BASE/VIAL · PowderANDA211908-001 · Prescription
- ZIPRASIDONE MESYLATE EQ 20MG BASE/VIAL · PowderThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA216091.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ziprasidone Mesylate
- Route
- Intramuscular
- Dosage form
- Powder
- Applicant
- MSN
- Status
- Prescription
- FDA approval
- 15 Sept 2022
- Application
- ANDA216091-001